Compare ZLAB & SHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZLAB | SHO |
|---|---|---|
| Founded | 2013 | 1995 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.0B |
| IPO Year | 2017 | 2004 |
| Metric | ZLAB | SHO |
|---|---|---|
| Price | $25.49 | $11.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 12 |
| Target Price | ★ $33.14 | $11.96 |
| AVG Volume (30 Days) | 713.1K | ★ 1.6M |
| Earning Date | 11-05-2026 | 11-06-2026 |
| Dividend Yield | N/A | ★ 3.16% |
| EPS Growth | ★ 38.46 | N/A |
| EPS | N/A | ★ 0.22 |
| Revenue | $460,156,000.00 | ★ $1,115,167,000.00 |
| Revenue This Year | N/A | $2.47 |
| Revenue Next Year | $26.50 | N/A |
| P/E Ratio | ★ N/A | $51.41 |
| Revenue Growth | ★ 15.33 | N/A |
| 52 Week Low | $15.96 | $8.69 |
| 52 Week High | $33.97 | $12.07 |
| Indicator | ZLAB | SHO |
|---|---|---|
| Relative Strength Index (RSI) | 51.50 | 59.24 |
| Support Level | $24.81 | $10.99 |
| Resistance Level | $27.20 | $11.46 |
| Average True Range (ATR) | 0.87 | 0.18 |
| MACD | -0.10 | 0.04 |
| Stochastic Oscillator | 41.28 | 82.61 |
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in California which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its Hotel Ownership Segment.